New drugs for Alzheimer’s are finally coming onto the market after decades of failed attempts to slow its devastating progression. But startup Cognito Therapeutics is taking a drug-free approach to treating the memory-robbing disease. The Cambridge, Massachusetts–based company is developing a headset to combat cognitive decline.
In results from a Phase II trial published March 6 in the journal Frontiers in Neurology, the company showed that its novel treatment is safe and reported early hints that it may also have benefits for Alzheimer’s patients.
“I think it’s extremely promising,” says Murali Doraiswamy, a professor of psychiatry and geriatrics at Duke University and an Alzheimer’s expert who
→ Continue reading at Wired - Science